Search

everythinglearnresearchcommunity

for

Search:↓

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

People with autoimmune skin diseases often have hearing problems and should get their hearing checked early.

Chemicals and stem cells combined have advanced regenerative medicine with few safety concerns, focusing on improving techniques and treatment effectiveness.

2011 dermatology discussions highlighted stem cell hair treatments, new lichen planopilaris therapies, skin side effects from cancer drugs, emerging allergens, and the link between food allergies and skin issues.

Accurate diagnosis of cicatricial alopecias requires thorough scalp examination and multiple biopsy techniques.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

Red blood cell folate levels are reliable indicators of long-term folate status in alopecia areata patients.

Terbinafine is more effective than itraconazole for toenail fungus, especially in older patients, and debridement improves its effectiveness.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

A man developed facial skin lesions after a stem cell transplant, which improved with specific treatments.

Hypothyroidism may cause certain types of hair loss.

More precise, personalized therapies are needed for autoimmune diseases.

Certain genetic markers, especially the MICA gene, are linked to alopecia areata.

Alopecia areata can be transferred through stem cell transplants from affected siblings.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

The review suggests that a special cell-derived treatment shows promise for various skin conditions and hair growth but needs more research for confirmation.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

People with Alopecia areata often have lower Vitamin D levels, which might affect the severity of their condition.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Alopecia areata and vitiligo can coexist, respond well to treatment, and may have a better prognosis together.

Amniotic allograft may be more effective than platelet-rich plasma for midface aging treatment.

The study found that a specific genetic variation in the TNFα gene is significantly linked to Alopecia Areata in the Jordanian Arab population.

A woman lost all her body hair after hepatitis C treatment, but it started to grow back a year after stopping the treatment.

Oral alitretinoin can quickly regrow hair in alopecia universalis.

Shock can be an early sign of Autoimmune Polyendocrine Syndrome Type II.

Inflammatory acne damages skin stem cells and reduces their growth, leading to atrophic acne scars.